Source:http://linkedlifedata.com/resource/pubmed/id/16156511
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-9-13
|
pubmed:abstractText |
The aim of this study was to investigate age-related changes in the density of calcitonin gene-related peptide (CGRP)-containing nerve fibers in spontaneously hypertensive rats (SHR) and the effects of long-term inhibition of the renin-angiotensin system on these changes. The density of immunocytochemically stained nerve fibers in the mesenteric artery was quantified by computer-assisted image processing. An age-related decrease in the density of CGRP-like immunoreactive (LI)-containing nerve fivers but not neuropeptide Y (NPY)-LI-containing sympathetic nerve fibers was found in the mesenteric artery of SHR but not Wistar Kyoto rats (WKY). The density of NPY-LI-containing sympathetic nerve fibers was significantly greater in SHR than in WKY. SHR were treated for 7 weeks with angiotensin converting enzyme inhibitor (0.005% temocapril), angiotensin II type-1 (AT1) receptor antagonist (0.025% losartan) or vasodilator (0.01% hydralazine) in their drinking water. Each drug treatment significantly lowered the systolic blood pressure measured by tail-cuff method. Long-term treatment of SHR with temocapril and losartan significantly increased the density of CGRP-LI-containing nerve fibers in mesenteric arteries. However, the density after hydralazine treatment was similar to the level in non-treated SHR. The density of NPY-LI-containing nerve fibers was not increased by any of the drug treatments. These results suggest that long-term inhibition of the renin-angiotensin system in SHR prevents remodeling of CGRPergic nerve fibers and prevents the reduction of CGRPergic nerve function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Calcitonin Gene-Related Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Hydralazine,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptide Y,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazepines,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/temocapril hydrochloride
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0916-9636
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
465-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16156511-Aging,
pubmed-meshheading:16156511-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16156511-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16156511-Animals,
pubmed-meshheading:16156511-Calcitonin Gene-Related Peptide,
pubmed-meshheading:16156511-Cell Count,
pubmed-meshheading:16156511-Hydralazine,
pubmed-meshheading:16156511-Hypertension,
pubmed-meshheading:16156511-Immunohistochemistry,
pubmed-meshheading:16156511-Losartan,
pubmed-meshheading:16156511-Male,
pubmed-meshheading:16156511-Mesenteric Arteries,
pubmed-meshheading:16156511-Nerve Fibers,
pubmed-meshheading:16156511-Neuropeptide Y,
pubmed-meshheading:16156511-Rats,
pubmed-meshheading:16156511-Rats, Inbred SHR,
pubmed-meshheading:16156511-Rats, Inbred WKY,
pubmed-meshheading:16156511-Renin-Angiotensin System,
pubmed-meshheading:16156511-Sympathetic Nervous System,
pubmed-meshheading:16156511-Thiazepines,
pubmed-meshheading:16156511-Vasodilator Agents
|
pubmed:year |
2005
|
pubmed:articleTitle |
Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
|
pubmed:affiliation |
Department of Clinical Pharmaceutical Science, Faculty of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|